Brez internetne povezave — prikazana je shranjena različica strani.

Orion Oyj B

FIEUR
← Na Filter Delnic

Orion Oyj B (LSE:0M2O) — Drug Manufacturers - General. Število borz, na katerih se trgujejo delnice družbe: 3. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O Podjetju

Spletna Stran
orionpharma.com
Sektor
Healthcare · Drug Manufacturers - General
Sedež
Espo, Finland
Izvršni Direktor
Liisa Hurme
Zaposleni
4 000
Na Borzi od
07.11.2007 (LSE:0M2O)
Delnice v Obtoku
108.99 mio.
Prosto Prenosljive Delnice
123.49 mio.
Tržna Kapitalizacija
11.42 mrd. EUR
Notranje Osebe
2.63%
Institucionalni Vlagatelji
45.48%
Delež Izplačila
41.3%
FCF
380 mio. EUR
Izplačilo / FCF
64%
Dolg
133 mio. EUR
0.3 let FCF
Dividendni Staž
21 let
Dobički, FCF in izplačane dividende — za 12 mesecev do 30.06.2026 (najnovejše poročilo podjetja).
Opis

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflammatory pain; Divina series for menopausal symptoms; Simdax for acute decompensated heart failure; Fareston for breast cancer; Quetiapine products for antipsychotic; Trexan for rheumatoid arthritis and cancer; Easyhaler product portfolio for asthma and COPD; and Dexdor, Precedex, and Dexmedetomidine products for human use. The company also provides Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, it offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells drugs and products manufactured by other companies. Additionally, the company provides self-care products, including non-prescription medicines, cosmetics, dietary supplements, vitamins, and skincare products. It also offers its products online. The company has a licensing agreement with Tenax Therapeutics, Inc. to develop oral levosimendan (TNX-103) for pulmonary hypertension in heart failure with preserved ejection fraction (PH-HFpEF); and Bayer for the development and commercialisation of darolutamide Nubeqa. Orion Oyj was founded in 1917 and is headquartered in Espo, Finland.

oglas

Borze in Oznake

BorzaOznakaValutaCenaVrsta
HE Nasdaq HelsinkiORNBV glavnaEUR80.8 -0.12%navadne delnice
LSE London Stock Exchange0M2O IOBEUR45.86 +0.00%navadne delnice
US USA StocksORINF OTCUSD92.05 +0.00%navadne delnice

Cena v 3 Mesecih

dan rasti dan padca ex-dividendni datum datum izplačilaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Dividende

Naslednji ex-datum: 2026-10-20 · 0.9 EUR (US:ORINF)
Na leto, US:ORINF: ≈1.8 EUR (1 izpl.)
Na leto, HE:ORNBV: 1.72 EUR (2 izpl.)

Orion Oyj B (ORINF) izplačuje dividende dvakrat letno. Na leto (12 mesecev do in vključno z najnovejšim napovedanim plačilom): 1.8 EUR na delnico (plačila: 1). Naslednji datum ex-dividende je 20.10.2026: 0.9 EUR na delnico, izplačilo 27.10.2026. Leta neprekinjenih dividend: 21.

Ex-DatumIzplačiloZnesek%VrstaOznaka
2026-10-20 napovedano2026-10-270.9000 EUR1.1/2.2 %polletnoUS:ORINF
2026-03-252026-04-020.9000 EUR1.3/2.6 %polletnoHE:ORNBV
2025-10-152025-10-230.8200 EUR1.2/2.4 %polletnoHE:ORNBV
2025-04-042025-04-140.8200 EUR1.5/2.9 %polletnoHE:ORNBV
2024-10-152024-10-230.8100 EUR1.7/3.4 %polletnoHE:ORNBV
2024-03-212024-04-030.8100 EUR2.3/2.3 %letnoHE:ORNBV
2023-03-23—1.6000 EUR3.7/3.7 %letnoHE:ORNBV
2022-03-24—1.5000 EUR3.5/3.5 %letnoHE:ORNBV

Novice Ta Teden

Sporočila za javnost s spletne strani za vlagatelje podjetja, ki se dnevno posodabljajo. Povezave vodijo na spletno stran podjetja. Naslovi so v izvirnem jeziku, kot na spletni strani podjetja.

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
BlackRock, Inc.≈6.43%7.07 mio.2025-04-24
VANGUARD STAR FUNDS-Vang…1.42%1.56 mio.2026-07-31
VANGUARD TAX-MANAGED FUN…0.95%1.04 mio.2026-06-30
iShares Trust-iShares Co…0.75%825 3442026-08-31
DFA INVESTMENT TRUST CO-…0.55%600 7792026-07-31
DFA INVESTMENT DIMENSION…0.45%497 9172026-07-31
Fidelity Concord Street…0.39%426 2452026-07-31
iShares Trust-iShares MS…0.35%379 6642026-08-31
SPDR-EUROPE-SSgA SPDR ET…0.34%374 2452026-07-31
VANGUARD Intl Eqy. INDEX…0.23%254 0972026-07-31
VANGUARD Intl Eqy. INDEX…0.23%253 8582026-07-31
Pacer Advisors, Inc.0%4852026-06-30